Skip to Content

About us

SOLTI is a leading academic research group in Oncology that develops clinical trials of excellence. Established in 1995, it has focused its efforts on developing national and international clinical trials and incorporating innovative translational research in all the projects in which it participates.

Currently, it has more than 400 members, as well as more than 80 sites distributed in Spain, Portugal, France and Italy.

Through the promotion of strategic alliances, patient empowerment, and excellence in clinical and translational research that translates into numerous high-impact scientific publications, SOLTI has become a benchmark in breast cancer in particular and aims to fulfill this role also in other types of tumors.

As an association, SOLTI has the following representative bodies:

  • General Assembly Members

The General Assembly is formed by more than 400 oncologists and health professionals involved in the development of clinical trials that are associated with the group.

  • Board Members

 

  • Board Honorific Member:

Dr Ana Casas - Fundación Actitud Frente al Cáncer

 

  • SOLTI statutes:

Read statutes

X

En Grupo Solti utilizamos cookies, propias y de terceros, analíticas, publicitarias y de elaboración de perfiles, basadas en hábitos de navegación del usuario, para mejorar la calidad del servicio, medir la audiencia y ofrecerle publicidad que pueda ser de su interés. Puede obtener más información en nuestra Política de Cookies.

Entendemos que acepta el uso de cookies en caso de que siga navegando.

Puede gestionar las cookies y aceptarlas o rechazarlas en el Panel de Configuración.